A Risk Assessment Tool for Resumption of Research Activities During the COVID-19 Pandemic.

ABSTRACT:

Rationale

The spread of severe acute respiratory syndrome coronavirus-2 has suspended many non-COVID-19 related research activities. Where restarting research activities is permitted, investigators need to evaluate the risks and benefits of resuming data collection and adapt procedures to minimize risk.

Objectives

In the context of the multicountry Household Air Pollution Intervention (HAPIN) trial, we developed a framework to assess the risk of each trial activity and to guide protective measures. Our goal is to maximize integrity of reseach aims while minimizing infection risk based on the latest understanding of the virus.

Methods

We drew on a combination of expert consultations, risk assessment frameworks, institutional guidance and literature to develop our frame

SUBMITTER: Simkovich SM 

PROVIDER: S-EPMC7668754 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature